SCHEMBL31435259

SCHEMBL31435259

Cc1cc(F)ccc1-c1nc(CN2CCC(C(=O)Nc3cccc(C(F)(F)F)c3)CC2)no1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UBE2M P61081 7/20 0.59
DCUN1D1 Q96GG9 7/20 0.59
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 1/20 0.52
KDM4E B2RXH2 2/20 0.49
USP2 O75604 1/20 0.49
LMNA P02545 1/20 0.49
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HSD17B10 Q99714 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
POLB P06746 2/20 0.47
EPHX2 P34913 1/20 0.47
CCR3 P51677 1/20 0.45
ACKR3 P25106 1/20 0.45
ALPL P05186 1/20 0.45
ALPI P09923 1/20 0.45
ALPG P10696 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31435237 0.89 UBE2M (0.51) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435226 0.88 UBE2M (0.57) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435220 0.85 UBE2M (0.60) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435238 0.82 DCUN1D1 (0.56) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435224 0.82 DCUN1D1 (0.53) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435229 0.81 DCUN1D1 (0.52) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435221 0.78 UBE2M (0.50) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL18657663 0.75 DCUN1D1 (1.00) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435231 0.72 UBE2M (0.46) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435222 0.72 UBE2M (0.46) UBE2MDCUN1D1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090928-A1 COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AQUINNAH PHARMACEUTICALS, INC. (US) 2025-05-01 WO claimed
WO-2025090928-A1 COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AQUINNAH PHARMACEUTICALS, INC. (US) 2025-05-01 WO disclosed